Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
MicroPort NeuroTech Limited ( (HK:2172) ) has shared an announcement.
MicroPort NeuroTech Limited has announced its upcoming Annual General Meeting scheduled for June 27, 2025, in Shanghai. Key agenda items include the approval of financial statements for 2024, a proposed final dividend of HK$0.11 per share, and the re-election and election of independent non-executive directors. Additionally, the company seeks shareholder approval for a mandate allowing the buyback of up to 10% of its issued shares, reflecting its strategic focus on shareholder value and corporate governance.
More about MicroPort NeuroTech Limited
MicroPort NeuroTech Limited operates in the medical technology industry, focusing on developing and manufacturing neuro-interventional medical devices. The company is known for its innovative solutions in the treatment of neurological disorders, aiming to enhance patient outcomes and expand its market presence globally.
Average Trading Volume: 5,565,471
Technical Sentiment Signal: Buy
Current Market Cap: HK$6.24B
For detailed information about 2172 stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue